Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2022;66:15–23.

Article  PubMed  PubMed Central  Google Scholar 

Masoud V, Pagès G. Targeted therapies in breast cancer: new challenges to fight against resistance. World J Clin Oncol. 2017;8:120.

Article  PubMed  PubMed Central  Google Scholar 

Yardim-Akaydin S, Karahalil B, Baytas SN. New therapy strategies in the management of breast cancer. Drug Discov Today. 2022;27:1755–62.

Article  CAS  PubMed  Google Scholar 

Lanfranchi AEFP. Breast cancer and induced abortion: a comprehensive review of breast development and pathophysiology, the epidemiologic literature, and proposal for creation of databanks to elucidate all breast cancer risk factors. Law Med. 2014;29:3–133.

Google Scholar 

Caldon CE, Daly RJ, Sutherland RL, Musgrove EA. Cell cycle control in breast cancer cells. J Cell Biochem. 2006;97:261–74.

Article  CAS  PubMed  Google Scholar 

Youness RA, El-Tayebi HM, Assal RA, Hosny K, Esmat G, Abdelaziz AI. MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc. Oncol Lett. 2016;12:2567–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kansara S, Singh A, Badal AK, Rani R, Baligar P, Garg M, et al. The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer. Semin Cancer Biol. 2023;95:1–12.

Article  CAS  PubMed  Google Scholar 

Morceau F, Chateauvieux S, Gaigneaux A, Dicato M, Diederich M. Long and short non-coding RNAs as regulators of hematopoietic differentiation. Int J Mol Sci. 2013;14:14744–70.

Article  PubMed  PubMed Central  Google Scholar 

Youness RA, Gad MZ. Long non-coding RNAs: functional regulatory players in breast cancer. Non-coding RNA Res. 2019;4:36–44.

Article  CAS  Google Scholar 

Tomar D, Yadav AS, Kumar D, Bhadauriya G, Kundu GC. Non-coding RNAs as potential therapeutic targets in breast cancer. Biochimica et Biophysica Acta (BBA)—Gene Regul Mech. 2020;1863:194378.

Article  CAS  Google Scholar 

Liang Z, Wu H, Xia J, Li Y, Zhang Y, Huang K, et al. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol. 2010;79:817–24.

Article  CAS  PubMed  Google Scholar 

Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, et al. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther. 2008;7:2152–9.

Article  CAS  PubMed  Google Scholar 

Liu Z, Sall A, Yang D. MicroRNA: an emerging therapeutic target and intervention tool. Int J Mol Sci. 2008;9:978–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho T-T, Zhou N, Huang J, Koirala P, Xu M, Fung R, et al. Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines. Nucleic Acids Res. 2015;43:e17–e17.

Article  PubMed  Google Scholar 

Wang D, Yin G-H. Non-coding RNAs mediated inflammation in breast cancers. Semin Cell Dev Biol. 2024;154:215–20.

Article  CAS  PubMed  Google Scholar 

Kung JTY, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193:651–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu S, Kong D, Chen Q, Ping Y, Pang D. Oncogenic long noncoding RNA landscape in breast cancer. Mol Cancer. 2017;16:129.

Article  PubMed  PubMed Central  Google Scholar 

Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lv M, Xu P, Wu Y, Huang L, Li W, Lv S, et al. LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer. Oncotarget. 2016;7:13047–59.

Article  PubMed  PubMed Central  Google Scholar 

Zhao L, Bi M, Zhang H, Shi M. Downregulation of NEAT1 suppresses cell proliferation, migration, and invasion in NSCLC Via sponging miR-153-3p. Cancer Biother Radiopharm. 2020;35:362–70.

CAS  PubMed  Google Scholar 

Cong S, Di X, Li R, Cao Y, Jin X, Tian C, et al. RBM10 regulates alternative splicing of lncRNA Neat1 to inhibit the invasion and metastasis of NSCLC. Cancer Cell Int. 2022;22:338.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lei C, Li S, Fan Y, Hua L, Pan Q, Li Y, et al. LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway. Cancer Biol Ther. 2022;23:1–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma J, Zhao W, Zhang H, Chu Z, Liu H, Fang X, et al. Long non-coding RNA ANRIL promotes chemoresistance in triple-negative breast cancer via enhancing aerobic glycolysis. Life Sci. 2022;306:120810.

Article  CAS  PubMed  Google Scholar 

Yu L, Zhang W, Wang P, Zhang Q, Cong A, Yang X, et al. LncRNA SNHG11 aggravates cell proliferation and migration in triple-negative breast cancer via sponging miR-2355-5p and targeting CBX5. Exp Ther Med. 2021;22:892.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tu Z, Schmöllerl J, Cuiffo BG, Karnoub AE. Microenvironmental regulation of long noncoding RNA LINC01133 promotes cancer stem cell-like phenotypic traits in triple-negative breast cancers. Stem Cells. 2019;37:1281–92.

Article  CAS  PubMed  Google Scholar 

Qiu-hui Yang Ye-qin Fu Wei-liang Feng Xing-fei Yu Ning Xu Hong-jian Yang Xi-ping Zhang. LncRNA MALAT1 regulates lymph node metastasis of triple-negative breast cancer through ceRNA mechanism. Res Sq. 2024

Sengupta P, Roy A, Roy L, Bose D, Halder S, Jana K, et al. Long non-coding intergenic RNA, LINC00273 induces cancer metastasis and stemness via miRNA sponging in triple negative breast cancer. Int J Biol Macromol. 2024;274:132730.

Article  CAS  PubMed  Google Scholar 

Tariq A, Hao Q, Sun Q, Singh DK, Jadaliha M, Zhang Y, et al. LncRNA-mediated regulation of SOX9 expression in basal subtype breast cancer cells. RNA. 2020;26:175–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Na-Er A, Xu YY, Liu YH, Gan YJ. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer. Eur Rev Med Pharmacol Sci. 2021;25:154–60.

CAS  PubMed  Google Scholar 

Hakiminia F, Jannat Alipoor F, Keshavarz M, Asadi MH. LncRNA PNKY Is upregulated in breast cancer and promotes cell proliferation and EMT in breast cancer cells. Noncoding RNA. 2023;9:25.

CAS  PubMed  PubMed Central  Google Scholar 

Han G, Bai X, Li F, Huang L, Hao Y, Li W, et al. Long non-coding RNA HANR modulates the glucose metabolism of triple negative breast cancer via stabilizing hexokinase 2. Heliyon. 2024;10:e23827.

Article  CAS  PubMed  Google Scholar 

Rezanejad H, Asadi MH. Long non-coding RNA VIM-AS1 is upregulated in high-grade invasive ductal breast tumors and promotes breast cancer metastasis via inducing EMT. Gene Rep. 2022;26:101501.

Article  CAS